A
Price
$143.82
Change
+$1.08 (+0.76%)
Updated
Oct 11 closing price
36 days until earnings call
WAT
Price
$357.97
Change
+$5.33 (+1.51%)
Updated
Oct 11 closing price
19 days until earnings call
Ad is loading...

A vs WAT

Header iconA vs WAT Comparison
Open Charts A vs WATBanner chart's image
Agilent Technologies
Price$143.82
Change+$1.08 (+0.76%)
Volume$1.43M
CapitalizationN/A
Waters
Price$357.97
Change+$5.33 (+1.51%)
Volume$270.46K
CapitalizationN/A
View a ticker or compare two or three
A vs WAT Comparison Chart
Loading...
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
A vs. WAT commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and WAT is a Buy.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (A: $143.82 vs. WAT: $357.97)
Brand notoriety: A and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 106% vs. WAT: 81%
Market capitalization -- A: $42.66B vs. WAT: $20.38B
A [@Medical Specialties] is valued at $42.66B. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileWAT’s FA Score has 3 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • WAT’s FA Score: 3 green, 2 red.
According to our system of comparison, A is a better buy in the long-term than WAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 3 TA indicator(s) are bullish while WAT’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 3 bullish, 6 bearish.
  • WAT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, WAT is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -0.79% price change this week, while WAT (@Medical Specialties) price change was +1.55% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

A is expected to report earnings on Nov 18, 2024.

WAT is expected to report earnings on Feb 11, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than WAT($20.4B). A has higher P/E ratio than WAT: A (34.82) vs WAT (31.78). WAT YTD gains are higher at: 8.729 vs. A (3.971). A has higher annual earnings (EBITDA): 1.69B vs. WAT (1B). WAT (2.44B) and A (2.56B) have identical debt. A has higher revenues than WAT: A (6.74B) vs WAT (2.96B).
AWATA / WAT
Capitalization42.7B20.4B209%
EBITDA1.69B1B169%
Gain YTD3.9718.72945%
P/E Ratio34.8231.78110%
Revenue6.74B2.96B228%
Total CashN/A396M-
Total Debt2.56B2.44B105%
FUNDAMENTALS RATINGS
A vs WAT: Fundamental Ratings
A
WAT
OUTLOOK RATING
1..100
8471
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
3545
SMR RATING
1..100
4019
PRICE GROWTH RATING
1..100
3019
P/E GROWTH RATING
1..100
6424
SEASONALITY SCORE
1..100
4450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (47) in the Biotechnology industry is somewhat better than the same rating for WAT (82) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than WAT’s over the last 12 months.

A's Profit vs Risk Rating (35) in the Biotechnology industry is in the same range as WAT (45) in the Medical Specialties industry. This means that A’s stock grew similarly to WAT’s over the last 12 months.

WAT's SMR Rating (19) in the Medical Specialties industry is in the same range as A (40) in the Biotechnology industry. This means that WAT’s stock grew similarly to A’s over the last 12 months.

WAT's Price Growth Rating (19) in the Medical Specialties industry is in the same range as A (30) in the Biotechnology industry. This means that WAT’s stock grew similarly to A’s over the last 12 months.

WAT's P/E Growth Rating (24) in the Medical Specialties industry is somewhat better than the same rating for A (64) in the Biotechnology industry. This means that WAT’s stock grew somewhat faster than A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AWAT
RSI
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
62%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bearish Trend 3 days ago
55%
Bullish Trend 3 days ago
65%
MACD
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
56%
Bullish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 5 days ago
64%
Bullish Trend 14 days ago
65%
Declines
ODDS (%)
Bearish Trend 11 days ago
55%
Bearish Trend 4 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
49%
Bearish Trend 3 days ago
52%
Aroon
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
66%
View a ticker or compare two or three
Ad is loading...
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X63193.023000747.933600
+1.20%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla